Article
Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.
Journal of clinical microbiology - 1 Feb 2015
Larrat Sylvie, Kulkarni Om, Claude Jean-Baptiste, Beugnot Réjane, Blum Michaël G B, Fusillier Katia, Lupo Julien, Tremeaux Pauline, Plages Agnès, Marlu Alice, Duborjal Hervé, Signori-Schmuck Anne, Francois Olivier, Zarski Jean-Pierre, Morand Patrice, Leroy Vincent
Abstract excerpt
Despite the gain in sustained virological responses (SVR) provided by protease inhibitors (PIs), failures still occur. The aim of this study was to determine if a baseline analysis of the NS3 region using ultradeep pyrosequencing (UDPS) can help to predict an SVR. Serum samples from 40 patients with previously nonresponding genotype 1 chronic hepatitis C who were retreated with triple therapy, including a PI,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
